# EDGAR Filing Document

**Accession Number:** 0001517681
**File Stem:** 0001641172-25-021451
**Filing Date:** 2025-7
**Character Count:** 2014
**Document Hash:** ee890349dc94c1b64b5a8a1d6560b28e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-021451.hdr.sgml**: 20250911

**ACCESSION NUMBER**: 0001641172-25-021451

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250729

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Propanc Biopharma, Inc.
- **CENTRAL INDEX KEY:** 0001517681
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 330662986
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 302/6 BUTLER STREET
- **CITY:** CAMBERWELL, VICTORIA
- **STATE:** C3
- **ZIP:** 3124
- **BUSINESS PHONE:** 61-03-9882-0780

**MAIL ADDRESS:**
- **STREET 1:** 302/6 BUTLER STREET
- **CITY:** CAMBERWELL, VICTORIA
- **STATE:** C3
- **ZIP:** 3124

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Propanc Health Group Corp
- **DATE OF NAME CHANGE:** 20110408

July 29, 2025

**<u>VIA EDGAR CORRESPONDENCE</u>**

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

---

| | |
|:---|:---|
| Re: | Propanc Biopharma, Inc.<br> Registration Statement on Form S-1, as amended<br> File No. 333- 282886 |
|  | **REQUEST FOR WITHDRAWAL OF ACCELERATION OF EFFECTIVENESS** |

---

Ladies and Gentlemen:

Reference is made to our letter, dated July 24, 2025 in which we requested acceleration of the effective date of the above referenced Registration Statement to 4:30 p.m., Eastern Time, on July 28, 2025. We are no longer requesting that such Registration Statement be declared effective at such time, and we hereby formally, and with immediate effect, withdraw our request for acceleration of the effective date.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| Propanc Biopharma, Inc. | Propanc Biopharma, Inc. |
| By: | */s/ James Nathanielsz* |
| Name: | James Nathanielsz |
| Title: | Chief Operating Officer |

---